CA2554440A1 - Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein - Google Patents

Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein Download PDF

Info

Publication number
CA2554440A1
CA2554440A1 CA002554440A CA2554440A CA2554440A1 CA 2554440 A1 CA2554440 A1 CA 2554440A1 CA 002554440 A CA002554440 A CA 002554440A CA 2554440 A CA2554440 A CA 2554440A CA 2554440 A1 CA2554440 A1 CA 2554440A1
Authority
CA
Canada
Prior art keywords
pea
amino acid
amino acids
homologous
node
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002554440A
Other languages
English (en)
Inventor
Amir Toporik
Dvir Dahary
Rotem Sorek
Sarah Pollock
Zurit Levine
Pinchas Akiva
Alexander Diber
Amit Novik
Osnat Sella-Tavor
Michal Ayalon-Soffer
Shira Walach
Shirley Sameah-Greenwald
Ronen Shemesh
Naomi Keren
Maxim Shklar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen USA Inc
Original Assignee
Compugen Usa, Inc.
Amir Toporik
Dvir Dahary
Rotem Sorek
Sarah Pollock
Zurit Levine
Pinchas Akiva
Alexander Diber
Amit Novik
Osnat Sella-Tavor
Michal Ayalon-Soffer
Shira Walach
Shirley Sameah-Greenwald
Ronen Shemesh
Naomi Keren
Maxim Shklar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen Usa, Inc., Amir Toporik, Dvir Dahary, Rotem Sorek, Sarah Pollock, Zurit Levine, Pinchas Akiva, Alexander Diber, Amit Novik, Osnat Sella-Tavor, Michal Ayalon-Soffer, Shira Walach, Shirley Sameah-Greenwald, Ronen Shemesh, Naomi Keren, Maxim Shklar filed Critical Compugen Usa, Inc.
Priority claimed from US11/043,842 external-priority patent/US20060183131A1/en
Publication of CA2554440A1 publication Critical patent/CA2554440A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
CA002554440A 2004-01-27 2005-01-27 Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein Abandoned CA2554440A1 (fr)

Applications Claiming Priority (51)

Application Number Priority Date Filing Date Title
US53912804P 2004-01-27 2004-01-27
US53912904P 2004-01-27 2004-01-27
US60/539,129 2004-01-27
US60/539,128 2004-01-27
US62091704P 2004-10-22 2004-10-22
US62091804P 2004-10-22 2004-10-22
US62085304P 2004-10-22 2004-10-22
US62092404P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US62091604P 2004-10-22 2004-10-22
US62065604P 2004-10-22 2004-10-22
US62097404P 2004-10-22 2004-10-22
US62100404P 2004-10-22 2004-10-22
US62097504P 2004-10-22 2004-10-22
US60/620,924 2004-10-22
US60/620,917 2004-10-22
US60/620,853 2004-10-22
US60/620,975 2004-10-22
US60/620,918 2004-10-22
US60/620,916 2004-10-22
US60/620,656 2004-10-22
US60/620,974 2004-10-22
US60/621,004 2004-10-22
US60/620,874 2004-10-22
US62113104P 2004-10-25 2004-10-25
US60/621,131 2004-10-25
US62817804P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62811104P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62012304P 2004-11-17 2004-11-17
US62823104P 2004-11-17 2004-11-17
US62816704P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US60/628,178 2004-11-17
US60/628,134 2004-11-17
US60/628,156 2004-11-17
US60/628,112 2004-11-17
US60/628,101 2004-11-17
US60/620,123 2004-11-17
US60/628,111 2004-11-17
US60/628,251 2004-11-17
US60/628,145 2004-11-17
US60/628,231 2004-11-17
US60/628,167 2004-11-17
US11/043,842 2005-01-27
PCT/IB2005/000433 WO2005072050A2 (fr) 2004-01-27 2005-01-27 Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein
US11/043,842 US20060183131A1 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Publications (1)

Publication Number Publication Date
CA2554440A1 true CA2554440A1 (fr) 2005-08-11

Family

ID=34831604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002554440A Abandoned CA2554440A1 (fr) 2004-01-27 2005-01-27 Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein

Country Status (3)

Country Link
AU (1) AU2005207882A1 (fr)
CA (1) CA2554440A1 (fr)
WO (1) WO2005072050A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891218A2 (fr) * 2005-06-08 2008-02-27 Compugen Ltd. Nouvelles sequences de nucleotides et d'acides amines, leurs dosages et methodes d'utilisation en vue du diagnostic
US20090215641A1 (en) * 2005-08-12 2009-08-27 Nihon University Gene involved in occurrence/recurrence of hcv-positive hepatocelluar carcinoma
UA109108C2 (uk) 2008-12-09 2015-07-27 Дженентек, Інк. Антитіло до pd-l1 та його застосування для посилення функції t-клітин
GB201004551D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer

Also Published As

Publication number Publication date
AU2005207882A1 (en) 2005-08-11
WO2005072050A9 (fr) 2010-01-14
WO2005072050A2 (fr) 2005-08-11

Similar Documents

Publication Publication Date Title
US7368548B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
US20060046257A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US7553948B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
DK2456889T3 (en) Markers of endometrial cancer
US7345142B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
US20060263786A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
US20100068736A1 (en) Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer
US20090215046A1 (en) Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
US7528243B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
CA2554703A1 (fr) Expression differentielle de marqueurs dans le cancer de l'ovaire
US7714100B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
WO2010061393A1 (fr) Séquences d'acides aminés et de nucléotides de variants de he4 et leurs procédés d'utilisation
CA2554440A1 (fr) Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein
CA2555509A1 (fr) Nouvelles sequences d'acides amines et de nucleotides, et dosages et methodes d'utilisation connexes pour le diagnostic du cancer du poumon
EP1954826A2 (fr) Nouvelles sequences de nucleotides et d'acides amines, ainsi que tests et procedes d'utilisation de ces sequences a des fins de diagnostic
WO2006043271A1 (fr) Nouvelles sequences d'acides amines et sequences nucleotidiques et methodes d'utilisation de celles-ci pour le diagnostic
EP1749025A2 (fr) Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon
US7906635B2 (en) Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
CA2554585A1 (fr) Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic de maladies cardiaques
CA2554707A1 (fr) Nouvelles sequences de nucleotides et d'acides amines; essais et methodes d'utilisation pour le diagnostic du cancer de a la prostate
CA2554623A1 (fr) Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon
AU2005207883A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
EP1732943A2 (fr) Nouvelles sequences nucelotidiques et d'acides amines, et leurs dosage et procedes d'utilisation pour le diagnostic du cancer du sein
JP2007520217A (ja) 新規ヌクレオチドおよびアミノ酸配列、ならびにそれを用いた乳癌診断のためのアッセイおよび使用方法

Legal Events

Date Code Title Description
FZDE Discontinued